首页 | 本学科首页   官方微博 | 高级检索  
   检索      


First report of glucose transporter 1 deficiency syndrome in Korea with a novel splice site mutation
Authors:Sat Byul Woo  Kon-Hee Lee  Hoon-Chul Kang  Hong Yang  Darryl C De Vivo  Sung Koo Kim
Institution:Department of Pediatrics, Hallym University College of Medicine, Seoul, Republic of Korea.
Abstract:Glucose transporter type 1 deficiency syndrome (Glut-1DS) is caused by autosomal dominant haplodeficiency or autosomal recessive with homozygous mutation of the glucose transporter 1 (SLC2A1) gene and is characterized by severe seizures, developmental delay, ataxia and acquired microcephaly. We describe the first known Korean patient with glucose transporter 1 deficiency syndrome, who had a novel mutation in the splice site. The patient began having intractable seizures at 4days of age that initially presented as eye blinking and apnea, evolving into generalized tonic seizures. A lumbar puncture revealed low glucose concentration in the cerebrospinal fluid (CSF) in the setting of normoglycemia (blood glucose, 106mg/dl; CSF glucose 21mg/dl, and CSF to blood glucose ratio 0.20). The results of a 3-O-methylglucose uptake study in erythrocytes (RBC) revealed that glucose uptake reduced to 48% of his parents in the patient. The patient responded to a ketogenic diet that was initiated at 4months of age and currently is on the modified Atkins diet (MAD) without seizures. He does not require antiepileptic medication. We diagnosed the first Glut-1 patient in Korea with a novel splice site mutation on the basis of clinical features, deficient glucose uptake and a mutation in the SLC2A1 gene.
Keywords:Glut-1  Glucose transporter type 1  Glut-1DS  Glut-1 deficiency syndrome  CSF  cerebrospinal fluid  EEG  electroencephalogram  RBC  erythrocyte  3OMG  3-O-methylglucose  MAD  modified Atkins diet
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号